Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Foster

Showing results (461-470 of 481) with videos related to

Pageof 49
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 2, 1994
Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoidJ J Yunis, N Mobini, E J Yunis, et al.
Histopathology|September 21, 2007
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcomeD M Berney, G Fisher, M W Kattan, et al.
Cornea|January 1, 1989
Factors influencing predilection and outcome in bacterial keratitisO G Gudmundsson, L D Ormerod, K R Kenyon, et al.
American Journal of Ophthalmology|May 1, 1997
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trialR B Nussenblatt, I Gery, H L Weiner, et al.
Oncology Reports|January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriersA V Mitra, C Jameson, Y Barbachano, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2012
Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancerN Vasiljević, A S Ahmad, C Beesley, et al.
British Journal of Cancer|March 19, 2009
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyD M Berney, A Gopalan, S Kudahetti, et al.
Liver|August 1, 1997
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liverS D Taylor-Robinson, J Sargentoni, J D Bell, et al.
British Journal of Cancer|February 25, 2012
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortJ Cuzick, D M Berney, G Fisher, et al.
British Journal of Cancer|August 27, 2009
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementC S Foster, A R Dodson, L Ambroisine, et al.
Pageof 49

Showing results (461-470 of 481) with videos related to

Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|August 2, 1994
Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoidJ J Yunis, N Mobini, E J Yunis, et al.
Histopathology|September 21, 2007
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcomeD M Berney, G Fisher, M W Kattan, et al.
Cornea|January 1, 1989
Factors influencing predilection and outcome in bacterial keratitisO G Gudmundsson, L D Ormerod, K R Kenyon, et al.
American Journal of Ophthalmology|May 1, 1997
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trialR B Nussenblatt, I Gery, H L Weiner, et al.
Oncology Reports|January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriersA V Mitra, C Jameson, Y Barbachano, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2012
Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancerN Vasiljević, A S Ahmad, C Beesley, et al.
British Journal of Cancer|March 19, 2009
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyD M Berney, A Gopalan, S Kudahetti, et al.
Liver|August 1, 1997
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liverS D Taylor-Robinson, J Sargentoni, J D Bell, et al.
British Journal of Cancer|February 25, 2012
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortJ Cuzick, D M Berney, G Fisher, et al.
British Journal of Cancer|August 27, 2009
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementC S Foster, A R Dodson, L Ambroisine, et al.
Pageof 49